Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience (vol 128, pg 440, 2016)

被引：2
|
作者：
Morillo-Gutierrez, B.
Beier, R.
Rao, K.
机构：
来源：
BLOOD | 2016年 / 128卷 / 21期
关键词：
D O I：
10.1182/blood-2016-10-745455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2585 / 2585
页数：1
相关论文
共 50 条
  • [41] Recent updates in chronic obstructive pulmonary disease (vol 128, pg 231, 2016)
    Recent, Garvey C.
    POSTGRADUATE MEDICINE, 2016, 128 (02)
  • [42] Comparable Outcome after Busulfan- or Treosulfan-Based Conditioning Regimen in Children Above 4 Years of Age with ALL Undergoing Allogeneic HSCT. Results from the Prospective International Forum-Trial
    Kalwak, Krzysztof
    Bader, Peter
    Dalle, Jean-Hugues
    Sedlacek, Petr
    Buechner, Jochen
    Ifversen, Marianne
    Svec, Peter
    Stein, Jerry
    Gungor, Tayfun
    Toporski, Jacek
    Diaz De Heredia, Cristina
    Bierings, Marc
    Meisel, Roland
    Ansari, Marc
    Balduzzi, Adriana
    Poetschger, Ulrike
    Peters
    Locatelli, Franco
    BLOOD, 2023, 142
  • [43] Does treosulfan-based preparative regimen allow safe and effective allogeneic HSCT for advanced hematologic malignancies in children demonstrating high risk of conventional regimen related toxicity?
    Wachowiak, J
    Chybicka, A
    Kowalczyk, J
    Boruczkowski, D
    Gorczynska, E
    Wojcik, B
    Leda, M
    Drabko, K
    Pieczonka, A
    Turkiewicz, D
    Kalwak, K
    Choma, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S25 - S25
  • [44] Treosulfan-Based Reduced-Toxicity Conditioning for Elderly Patients with High-Risk Myelodysplastic and Myeloproliferative Disease for Allogeneic Hematopoietic Stem Cell Transplantation
    Neagoie, Adela Maria
    Wais, Verena
    Gantner, Andrea
    Schnell, Jacqueline
    Strauss, Katrin
    Weidt, Conrad
    Dohner, Hartmut
    Bunjes, Donald Werner
    Sala, Elisa
    BLOOD, 2023, 142
  • [45] Successful treatment of chronic granulomatous disease with myeloablative conditioning and allogeneic bone marrow transplantation - A single-centre experience
    Gozdzik, J.
    Pituch-Noworolska, A.
    Czogala, W.
    Skoczen, S.
    Baran, J.
    Krasowska-Kwiecien, A.
    Wiecha, O.
    Zembala, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S147 - S147
  • [46] Preliminary results of novel Treosulfan-based conditioning regimen for allogenic HSCT with TCRαβ/CD19 graft depletion in Nijmegen breakage syndrome after five years of Busulfan experience
    Laberko, Alexandra
    Gutovskaya, Elena
    Radigina, Svetlana
    Kozlovskaya, Svetlana
    Shipitsina, Irina
    Deripapa, Elena
    Shcherbina, Anna
    Maschan, Michael
    Maschan, Alexei
    Balashov, Dmitry
    BONE MARROW TRANSPLANTATION, 2018, 53 : 531 - 531
  • [47] Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease-Single Centre Experience (vol 31, pg 332, 2011)
    Gozdzik, Jolanta
    Pituch-Noworolska, Anna
    Skoczen, Szymon
    Czogala, Wojciech
    Wedrychowicz, Anna
    Baran, Jaroslaw
    Krasowska-Kwiecien, Aleksandra
    Wiecha, Oktawiusz
    Zembala, Marek
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (06) : 1157 - 1157
  • [48] Multicentre study of a treosulfan-based conditioning regimen for children with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing allogeneic haematopoietic cell transplantation (allo-HCT)
    Nemecek, E. R.
    Hilger, R.
    Adams, A.
    Shaw, B.
    Kiefer, D.
    Le-Rademacher, J.
    Levine, J.
    Yanik, G.
    Leung, W.
    Talano, J. -A.
    Haut, P.
    Delgado, D.
    Kapoor, N.
    Petrovic, A.
    Adams, R.
    Hanna, R.
    Rangarajan, H.
    Dalal, J.
    Chewning, J.
    Verneris, M.
    Epstein, S.
    Pulsipher, M.
    Delaney, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S45 - S45
  • [49] Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments (vol 117, pg 285, 2016)
    Zicari, Anna Maria
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : 573 - 573
  • [50] Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease
    Floeth, Matthias
    Beckmann, Elena
    Reicherts, Christian
    Marx, Julia
    Call, Simon
    Shaforostova, Inna
    Esseling, Eva
    Albring, Jorn
    Mikesch, Jan-Henrik
    Schliemann, Christoph
    Lenz, Georg
    Stelljes, Matthias
    BLOOD, 2022, 140 : 7587 - 7588
12345